VEGFA and colorectal cancer: The 5-year survival rates for all colorectal cancer patients were 91.3% among cases with no VEGF/PROK1 expression, 76.4% among cases that expressed either protein, and 57.3% among cases that expressed both proteins; the latter rate indicated a significantly poorer prognosis (Fig. 1D).